Side-by-side comparisons built from each program's own pages and the FDA labels. Program comparisons use printed prices with read dates and spell out the 12-month arithmetic; drug comparisons use the prescribing information and the head-to-head trials.
Program comparisons
NexLife vs Hims & Hers: compounded all-in pricing or brand drugs with a membership
NexLife lists compounded semaglutide at $109 a month with no membership; Hims lists brand Wegovy from $199 plus a $149 membership. 12-month math, verdict.
NexLife vs Ro: compounded tirzepatide against brand Zepbound with a membership
NexLife's 12-month compounded tirzepatide plan totals $1,380; Ro's Zepbound KwikPen runs $299 to $449 a fill plus a $74+ membership. First-year math, verdict.
NexLife vs Henry Meds: two compounded GLP-1 programs, two levels of disclosure
NexLife prints $129 a month for compounded tirzepatide; Henry Meds prints only "starts at $179/month". A month-to-month year compared, pharmacies, trade-offs.
NexLife vs Mochi Health: one flat price or a price that follows your dose
NexLife charges $109 a month for compounded semaglutide at every dose; Mochi charges $60 to $99 by dose plus a membership. 3 dose scenarios over 12 months.
NexLife vs Form Health: printed cash prices or insurance-billed obesity medicine
NexLife prints $1,380 for a year of compounded tirzepatide; Form Health prints no prices but bills insurance and Medicare. Who wins when, with Bridge math.
NexLife vs Calibrate: an all-in cash price or a coaching program with insurance-paid drugs
Calibrate charges $199 a month for its program, drugs via insurance; NexLife's compounded tirzepatide is $1,380 a year all-in. Two year-one scenarios.
NexLife vs Found: compounded GLP-1 prices, billing cycles and insurance options
NexLife vs Found: $129 vs $359 month to month for compounded tirzepatide, 12 charges vs 13 billing cycles a year, and when Found's insurance track matters.
Hims & Hers vs Ro: how their GLP-1 memberships compare
Hims and Ro both sell brand GLP-1s through a membership, with medication billed separately. Prices printed in September 2026, 12-month math, the FTC case.
Drug comparisons
Semaglutide vs tirzepatide: head-to-head results and what each costs
In SURMOUNT-5, tirzepatide averaged 20.2% weight loss vs 13.7% for semaglutide at 72 weeks. Side effects, brand self-pay prices and compounded medians.
Mounjaro vs Zepbound: same molecule, different labels
Mounjaro and Zepbound are both tirzepatide, 2.5 to 15 mg weekly, but one is for type 2 diabetes and one for weight and sleep apnea. Labels, prices, coverage.
Ozempic vs Wegovy: what differs besides the name
Ozempic tops out at 2 mg for type 2 diabetes; Wegovy goes to 2.4 mg and 7.2 mg for weight. Dose ladders, label uses and NovoCare prices read Nov 8, 2026.
For the full price table see the price index; for single-program detail see the provider reviews.